Lobe Sciences Balans Gezondheid
Financiële gezondheid criteriumcontroles 2/6
Lobe Sciences has a total shareholder equity of CA$-1.1M and total debt of CA$2.2M, which brings its debt-to-equity ratio to -199%. Its total assets and total liabilities are CA$2.0M and CA$3.1M respectively.
Belangrijke informatie
-199.0%
Verhouding schuld/eigen vermogen
CA$2.21m
Schuld
| Rente dekkingsratio | n/a |
| Contant | CA$40.99k |
| Aandelen | -CA$1.11m |
| Totaal verplichtingen | CA$3.07m |
| Totaal activa | CA$1.96m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: LOBE has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Langlopende schulden: LOBE has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: LOBE has negative shareholder equity, which is a more serious situation than a high debt level.
Schuld verminderen: LOBE's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: LOBE has sufficient cash runway for 0 months based on last reported free cash flow, but has since raised additional capital.
Voorspelling contante baan: LOBE is forecast to have sufficient cash runway for 0 months based on free cash flow estimates, but has since raised additional capital.